Modern Radiotherapy and Cardiac Toxicity in Breast Cancer

Radiotherapy (RT) is a mainstay of Breast Cancer (BC) patients therapy. Nonetheless, unintended irradiation of the heart and its substructures can result in cardiac toxicity, jeopardizing long-term survivors’ quality of life (QOL). Advances in RT delivery techniques deeply impacted this clinical sce...

Full description

Bibliographic Details
Main Authors: Giuseppe Carlo Iorio, Valeria Chiofalo, Umberto Ricardi
Format: Article
Language:English
Published: IMR Press 2023-07-01
Series:Clinical and Experimental Obstetrics & Gynecology
Subjects:
Online Access:https://www.imrpress.com/journal/CEOG/50/7/10.31083/j.ceog5007138
_version_ 1797768998898630656
author Giuseppe Carlo Iorio
Valeria Chiofalo
Umberto Ricardi
author_facet Giuseppe Carlo Iorio
Valeria Chiofalo
Umberto Ricardi
author_sort Giuseppe Carlo Iorio
collection DOAJ
description Radiotherapy (RT) is a mainstay of Breast Cancer (BC) patients therapy. Nonetheless, unintended irradiation of the heart and its substructures can result in cardiac toxicity, jeopardizing long-term survivors’ quality of life (QOL). Advances in RT delivery techniques deeply impacted this clinical scenario. Indeed, given the non-negligible burden of cardiotoxicity, modern cardiac sparing approaches have a pivotal role. Nonetheless, further evidence is eagerly awaited regarding patients’ selection, clinical predictors, biological markers, and particularly heart substructures dose-constraints.
first_indexed 2024-03-12T21:02:27Z
format Article
id doaj.art-e1ceae0a848c4f55857800c6c4c87903
institution Directory Open Access Journal
issn 0390-6663
language English
last_indexed 2024-03-12T21:02:27Z
publishDate 2023-07-01
publisher IMR Press
record_format Article
series Clinical and Experimental Obstetrics & Gynecology
spelling doaj.art-e1ceae0a848c4f55857800c6c4c879032023-07-31T06:06:12ZengIMR PressClinical and Experimental Obstetrics & Gynecology0390-66632023-07-0150713810.31083/j.ceog5007138S0390-6663(23)02079-1Modern Radiotherapy and Cardiac Toxicity in Breast CancerGiuseppe Carlo Iorio0Valeria Chiofalo1Umberto Ricardi2Department of Oncology, University of Torino, 10125 Torino, ItalyDepartment of Oncology, University of Torino, 10125 Torino, ItalyDepartment of Oncology, University of Torino, 10125 Torino, ItalyRadiotherapy (RT) is a mainstay of Breast Cancer (BC) patients therapy. Nonetheless, unintended irradiation of the heart and its substructures can result in cardiac toxicity, jeopardizing long-term survivors’ quality of life (QOL). Advances in RT delivery techniques deeply impacted this clinical scenario. Indeed, given the non-negligible burden of cardiotoxicity, modern cardiac sparing approaches have a pivotal role. Nonetheless, further evidence is eagerly awaited regarding patients’ selection, clinical predictors, biological markers, and particularly heart substructures dose-constraints.https://www.imrpress.com/journal/CEOG/50/7/10.31083/j.ceog5007138breast cancerradiotherapycardiac toxicitydibhqolcardiac sparing
spellingShingle Giuseppe Carlo Iorio
Valeria Chiofalo
Umberto Ricardi
Modern Radiotherapy and Cardiac Toxicity in Breast Cancer
Clinical and Experimental Obstetrics & Gynecology
breast cancer
radiotherapy
cardiac toxicity
dibh
qol
cardiac sparing
title Modern Radiotherapy and Cardiac Toxicity in Breast Cancer
title_full Modern Radiotherapy and Cardiac Toxicity in Breast Cancer
title_fullStr Modern Radiotherapy and Cardiac Toxicity in Breast Cancer
title_full_unstemmed Modern Radiotherapy and Cardiac Toxicity in Breast Cancer
title_short Modern Radiotherapy and Cardiac Toxicity in Breast Cancer
title_sort modern radiotherapy and cardiac toxicity in breast cancer
topic breast cancer
radiotherapy
cardiac toxicity
dibh
qol
cardiac sparing
url https://www.imrpress.com/journal/CEOG/50/7/10.31083/j.ceog5007138
work_keys_str_mv AT giuseppecarloiorio modernradiotherapyandcardiactoxicityinbreastcancer
AT valeriachiofalo modernradiotherapyandcardiactoxicityinbreastcancer
AT umbertoricardi modernradiotherapyandcardiactoxicityinbreastcancer